GENERAL ATLANTIC, L.P. Diversified Active

CIK: 0001017645 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $2,872,723 (100.0% shares, 0.0% debt)

Holdings (13)

New Positions (1)

NRIX NURIX THERAPEUTICS 3.2%

Value ($000) $92,899 Shares 4,897,159 Est. Cost $14.37 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
NRIX	NURIX THERAPEUTICS	4,897,159	$92,899	3.2%	$14.37	0.0%	COM	67080M103

Increased Positions (2)

CHYM CHIME 18.6%

Value ($000) $535,106 (+38.1%) Shares 21,259,683 (+10.7%) Est. Cost $31.82 Unrealized -33.2%

RVMD REVOLUTION MEDICINES 7.8%

Value ($000) $224,050 (+93.9%) Shares 2,812,928 (+13.7%) Est. Cost $42.33 Unrealized +54.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CHYM	CHIME	21,259,683 (+10.7%)	$535,106 (+38.1%)	18.6%	$31.82	-33.2%	COM SHS CL A	16935C109
RVMD	REVOLUTION MEDICINES	2,812,928 (+13.7%)	$224,050 (+93.9%)	7.8%	$42.33	+54.9%	COM	76155X100

Exited Positions (4)

— AKERO THERAPEUTICS 9.5%

Value ($000) $272,250 Shares 5,733,989 Est. Cost $34.38 Unrealized —

RPRX ROYALTY PHARMA 1.8%

Value ($000) $52,920 Shares 1,500,000 Est. Cost $49.50 Unrealized -23.0%

ADAG ADAGENE 0.3%

Value ($000) $7,527 Shares 3,782,339 Est. Cost $3.09 Unrealized —

ALMS ALUMIS 0.2%

Value ($000) $5,177 Shares 1,297,530 Est. Cost $4.72 Unrealized +47.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	AKERO THERAPEUTICS	5,733,989	$272,250	9.5%	$34.38	—	—	00973Y108
RPRX	ROYALTY PHARMA	1,500,000	$52,920	1.8%	$49.50	-23.0%	—	G7709Q104
ADAG	ADAGENE	3,782,339	$7,527	0.3%	$3.09	—	—	005329107
ALMS	ALUMIS	1,297,530	$5,177	0.2%	$4.72	+47.8%	—	022307102

Decreased Positions (4)

ALHC ALIGNMENT HEALTHCARE 9.1%

Value ($000) $260,063 (-38.6%) Shares 13,167,733 (-45.8%) Est. Cost $19.55 Unrealized -8.1%

XP XP, INC 12.9%

Value ($000) $371,585 (-22.5%) Shares 22,699,133 (-11.0%) Est. Cost $31.26 Unrealized -43.7%

BULL WEBULL 0.0%

Value ($000) $395 (-99.6%) Shares 50,816 (-99.3%) Est. Cost $14.98 Unrealized -32.9%

CNTA CENTESSA PHARMACEUTICALS 5.3%

Value ($000) $153,004 (-34.8%) Shares 6,117,715 (-36.8%) Est. Cost $17.55 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALHC	ALIGNMENT HEALTHCARE	13,167,733 (-45.8%)	$260,063 (-38.6%)	9.1%	$19.55	-8.1%	COM	01625V104
XP	XP, INC	22,699,133 (-11.0%)	$371,585 (-22.5%)	12.9%	$31.26	-43.7%	CL A	G98239109
BULL	WEBULL	50,816 (-99.3%)	$395 (-99.6%)	0.0%	$14.98	-32.9%	ORD SHS	G9572D103
CNTA	CENTESSA PHARMACEUTICALS	6,117,715 (-36.8%)	$153,004 (-34.8%)	5.3%	$17.55	—	ADS	152309100

Unchanged Positions (6)

PHVS PHARVARIS 7.8%

Value ($000) $222,867 Shares 8,031,252 Est. Cost $22.20 Unrealized +8.5%

ALKT ALKAMI 9.6%

Value ($000) $276,643 Shares 11,991,480 Est. Cost $34.49 Unrealized -36.0%

DLO DLOCAL 23.0%

Value ($000) $659,726 Shares 46,656,695 Est. Cost $34.47 Unrealized -59.1%

EWCZ EUROPEAN WAX CENTER 1.6%

Value ($000) $47,198 Shares 13,110,492 Est. Cost $22.36 Unrealized -83.3%

RSKD RISKIFIED 0.9%

Value ($000) $26,465 Shares 5,324,998 Est. Cost $28.06 Unrealized -82.8%

GROV GROVE COLLABORATIVE 0.1%

Value ($000) $2,722 Shares 2,474,859 Est. Cost $1.69 Unrealized -19.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	PHARVARIS	8,031,252	$222,867	7.8%	$22.20	+8.5%	COM	N69605108
ALKT	ALKAMI	11,991,480	$276,643	9.6%	$34.49	-36.0%	COM	01644J108
DLO	DLOCAL	46,656,695	$659,726	23.0%	$34.47	-59.1%	CL A	G29018101
EWCZ	EUROPEAN WAX CENTER	13,110,492	$47,198	1.6%	$22.36	-83.3%	CL A	29882P106
RSKD	RISKIFIED	5,324,998	$26,465	0.9%	$28.06	-82.8%	CL A	M8216R109
GROV	GROVE COLLABORATIVE	2,474,859	$2,722	0.1%	$1.69	-19.3%	CL A	39957D201